VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 380 filers reported holding VIKING THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $30,071,725 | -21.5% | 567,284 | +21.4% | 0.15% | -23.2% |
Q1 2024 | $38,311,712 | +8551.4% | 467,216 | +1656.6% | 0.19% | +9400.0% |
Q1 2023 | $442,840 | -34.5% | 26,597 | -60.9% | 0.00% | -33.3% |
Q1 2019 | $676,000 | +215.9% | 68,000 | +142.9% | 0.00% | +200.0% |
Q4 2018 | $214,000 | -64.9% | 28,000 | -20.0% | 0.00% | -50.0% |
Q3 2018 | $610,000 | – | 35,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |